Processa Pharmaceuticals Announces PCS12852 Successfully Improves the Clinical Symptoms Associated…
A 0.5 mg daily dose of PCS12852 administered over 28 days in gastroparesis patients successfully improved gastroparesis symptoms…
GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.